We have earlier reported the potential of 170 Tm-EDTMP as an alternative cost-effective
radiopharmaceutical of 89 SrCl 2 for bone pain palliation application. Encouraging results …

Introduction: Metastron ({sup 89} SrCl {sub 2}) is a radiopharmaceutical currently used for
bone pain palliation in several countries since the long half-life of {sup 89} Sr (50.5 days) …

INTRODUCTION: Metastron (89SrCl2) is a radiopharmaceutical currently used for bone pain
palliation in several countries since the long half-life of 89Sr (50.5 days) favors wider …

Radiochemical studies and biological evaluation in animal models have shown superior
radiochemical properties and better clearance pattern for 177 Lu-DOTMP compared with …

1441 Objectives To compare the therapeutic efficacy of [153] Sm-EDTMP and [177] Lu-
EDTMP in painful wide spread skeletal metastases in breast, prostate and lung cancer …

Purpose The purpose of this study was to evaluate the efficacy and safety of 177 Lu-EDTMP
for pain palliation in patients with bone metastases from castration-resistant prostate and …

The aim of this multi-centre study was to assess the efficacy and toxicity of Samarium-153
EDTMP (Sm-153 EDTMP) in the palliative treatment of painful skeletal metastases. Four …

OBJECTIVE: Radiolabeled bisphosphonates have found wide clinical use in nuclear
medicine for palliative therapy of bone metastases. 177Lu-EDTMP was used to relieve …

1211 Objectives To assess the pharmacokinetics and to establish the safety profile by
applying common toxicity criteria using dose escalation protocol. Methods 15 patients (12 M …

Purpose The aim of the paper is to calculate the dose to bone surface and bone volume
using a Monte Carlo particle transport model and to give quantitative arguments for activity …